利用循环滋养细胞进行囊性纤维化无创产前筛查:检测50种最常见致病变异
本研究旨在开发基于细胞的無創產前檢測(NIPT)筛查50种最常见囊性纤维化(CF)变异,采集30例接受侵入性诊断的孕妇血样,27例成功获取循环滋养细胞,用片段长度分析和新建的NGS方法检测,27例结果均与侵入性检测一致。
要点
- 基于循环滋养细胞的NIPT可检测50种最常见CF致病变异。
- 27例样本中两种方法结果均与侵入性诊断一致。
- 该检测无需伴侣及先证者样本即可提供可靠结果。
核心结论
- 基于细胞的NIPT用于CF筛查可提供可靠结果,且无需伴侣和先证者样本。
研究设计与样本
- 研究采集30例接受侵入性诊断的孕妇血样,其中27例成功获取循环滋养细胞,采用片段长度分析和新建的基于NGS的CF分析方法进行检测。
主要发现
- 27例中基于细胞的NIPT两种方法均给出结果,且与侵入性检测结果一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cystic fibrosis (CF) is one of the most common severe autosomal recessive disorders. Prenatal or preconception CF screening is offered in some countries. A maternal blood sample in early pregnancy can provide circulating trophoblasts and offers a DNA source for genetic analysis of both the mother and the fetus. This study aimed to develop a cell-based noninvasive prenatal test (NIPT) to screen for the 50 most common CF variants. METHODS: Blood samples were collected from 30 pregnancies undergoing invasive diagnostics and circulating trophoblasts were harvested in 27. Cystic fibrosis testing was conducted using two different methods: by fragment length analysis and by our newly developed NGS-based CF analysis. RESULTS: In all 27 cases, cell-based NIPT provided a result using both methods in agreement with the invasive test result. CONCLUSION: This study shows that cell-based NIPT for CF screening provides a reliable result without the need for partner- and proband samples.
引用
- Jeppesen LD, Lildballe DL, Hatt L, et al. Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease-causing variants. Prenat Diagn. 2022. PMID: 36447355. doi:10.1002/pd.6276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。